Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04925609
Title Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors (Briga-PED)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Princess Maxima Center for Pediatric Oncology
Indications

Advanced Solid Tumor

inflammatory myofibroblastic tumor

anaplastic large cell lymphoma

Therapies

Brigatinib

Age Groups: child | adult
Covered Countries FRA

Additional content available in CKB BOOST